Scientific deep-dive
How to Travel With a GLP-1: The Complete Guide for Pens, Vials, and TSA
FDA-sourced storage windows for Wegovy, Ozempic, Zepbound, Mounjaro, and Foundayo, plus TSA carry-on rules, ice pack guidance, time-zone advice, and what to do if your pen gets warm.
- Travel
- Storage
- FDA sourced
Traveling with a GLP-1 is one of the most-asked, least-clearly- answered questions in weight-loss medicine. The pens are refrigerated drugs, but they are also explicitly designed to survive a window of room temperature — and that window is different for each drug. Wegovy gives you 28 days. Zepbound and Mounjaro give you 21. Ozempic gives you 56. Foundayo, the new oral pill, gives you forever, because it doesn't need a fridge at all. This guide pulls every number directly from the FDA-approved prescribing information for each drug, walks through TSA's actual carry-on rules for injectables and ice packs, and answers the practical questions patients consistently search for: what happens if my pen gets warm, what to do if I forget it at home, and how to handle time-zone changes on a once-weekly schedule.
Why GLP-1s need a fridge in the first place
Semaglutide and tirzepatide are peptide drugs — long chains of amino acids that fold into a specific three-dimensional shape to bind the GLP-1 receptor. Heat, freezing, and prolonged room temperature all encourage that chain to unfold, aggregate, or chemically degrade. The manufacturer's long-term shelf life (typically 24 months) is only valid when the drug is held between 2 and 8 degrees Celsius (36-46°F) the entire time before first use [1, 2, 3, 4]. The room-temperature windows that show up on the labels are not infinite — they are the boundary the manufacturer was able to validate with actual stability testing, and beyond them the drug's potency is no longer guaranteed.
For travel, this means two things. First, you can absolutely leave the fridge for a trip — the windows are forgiving enough that a one or two week vacation is well within tolerance for every approved drug. Second, you should treat the upper temperature limit (30°C / 86°F) as a hard ceiling. A pen sitting in a hot car at 110°F is in a different stability regime than the labeled window contemplates, and the conservative call is to discard.
Storage tolerances at a glance
These numbers come directly from Section 16 of each FDA-approved prescribing information document [1, 2, 3, 4] and from Eli Lilly's Foundayo approval materials [6]:
| Drug | Form | Out-of-fridge window | Max temperature |
|---|---|---|---|
| Wegovy (semaglutide 2.4 mg) | Single-use pen | Up to 28 days, then discard | 30°C / 86°F |
| Ozempic (semaglutide) | Multi-dose pen, in use | Up to 56 days after first use | 30°C / 86°F |
| Zepbound (tirzepatide) | Single-use pen | Up to 21 days, then discard | 30°C / 86°F |
| Mounjaro (tirzepatide) | Single-use pen | Up to 21 days, then discard | 30°C / 86°F |
| Foundayo (orforglipron) | Oral tablet | No refrigeration required | Standard room temperature |
Two practical observations. The 21-day Zepbound and Mounjaro windows are the tightest, so tirzepatide users on a long trip should plan around that number, not the more generous Wegovy figure. And the Foundayo tablet is the obvious winner for any traveler who hates the cold-chain logistics — no fridge, no ice pack, no TSA conversation, just a pill bottle in your carry-on. For more on the daily-pill protocol, see our Foundayo (orforglipron) practical guide.
TSA rules: pens, syringes, and ice packs
Injectable medications and the cooling supplies they need are explicitly exempt from the standard 3-1-1 liquid rule when carried in carry-on baggage [5]. The relevant TSA carve-outs:
- Injectable drugs are allowed in carry-on. GLP-1 pens, insulin syringes, and the multi-dose vials used for compounded semaglutide or tirzepatide can all go through security in your carry-on bag. There is no quantity limit on medically necessary liquid medication.
- Frozen ice packs are allowed. An ice pack accompanying a refrigerated medication is exempt from the 3.4 oz limit. TSA prefers the ice pack to be fully frozen and solid at the checkpoint; partially melted slush is technically a liquid and can occasionally trigger extra screening.
- Declare at the checkpoint. You don't have to declare medications, but doing so up front avoids confusion. Tell the TSA officer you have a refrigerated injectable medication and an ice pack, and they will route you through the standard medical screening.
- Documentation is helpful but not required. A prescription label on the original carton is the cleanest option. A doctor's letter is also fine. Patients on compounded GLP-1 from a 503A pharmacy should bring the pharmacy label and ideally the patient information sheet.
Carry-on, never check
This is the single most important rule in this article. Cargo holds on commercial aircraft are not climate controlled in any meaningful sense — temperatures regularly drop below freezing at cruising altitude and can swing above 100°F on a hot tarmac. Either extreme will destroy a GLP-1. The FDA-approved labels for all four injectable drugs explicitly say to discard a pen that has been frozen, even if it has thawed and looks visually normal [1, 2, 3, 4]. Checked baggage is the single most reliable way to expose your medication to freezing temperatures. Always keep the pen, ice pack, and travel case in your cabin bag.
Cooler bags and gear that actually work
For trips up to a few days, a basic insulated medication travel case with a refreezable gel ice pack is sufficient. For longer trips, the evaporative cooling cases (FRIO and similar) are popular because they stay cool for 45 hours from a single tap-water soak with no ice pack at all — useful if you'll be in transit longer than your ice pack will stay frozen.
Two practical notes. First, do not let an ice pack contact the pen directly. Wrap the ice pack in a small cloth or use a case with an insulated divider, because direct ice-pack contact can push the pen below freezing — and a frozen pen is a discarded pen. Second, if you're traveling for more than a week and want certainty, a cheap wireless thermometer (MedAngel, ThermoPro, or any small temperature logger) lets you verify the case stayed in the 2-30°C window the whole time.
Time zones and the once-weekly schedule
Wegovy, Ozempic, Zepbound, and Mounjaro are all weekly injectables. The once-weekly cadence is forgiving because steady-state plasma levels build over weeks, not days — a single dose shifted by a few hours has essentially no clinical effect. Practical guidance:
- Short trips (under a week): stay on your home time zone. If your usual injection day is Sunday morning at 9 a.m. Eastern, inject at 9 a.m. Eastern even if that's the middle of the afternoon at your destination.
- Long trips with a big time-zone shift: either keep injecting on home time, or shift your weekly dose by a few hours per week until it lines up with the local schedule. The FDA labels for all four weekly drugs explicitly allow shifting the dose day as long as at least two days have passed since the last dose.
- Foundayo (daily oral): take it in the morning local time on an empty stomach, the same way you would at home. Do not double up if you've already taken your home-time dose for the day.
What to do if your pen gets warm
The labeled out-of-fridge windows are the answer to almost every “what happens if” question. A Wegovy pen that sat at room temperature for two days during a road trip is fine — that's well within the 28-day window. A Zepbound pen that stayed in a beach bag at 80°F for a long weekend is fine — it's within the 21-day window and well below the 86°F ceiling. The scenarios where you should actually discard:
- Sustained exposure above 86°F. A pen left in a hot car (interior temperatures of 110-140°F are common in summer) has exceeded the validated stability window. Discard.
- Out of the fridge longer than the labeled window. A Wegovy pen at room temperature for 30 days, a Zepbound or Mounjaro pen at room temperature for 25 days, or an Ozempic pen in use for 60 days — discard, even if it looks normal.
- Any freezing event. If the pen ever frozen (ice pack pressed against it, hotel mini-fridge set too cold, checked baggage at altitude), discard. Frozen GLP-1 should not be used [1, 2, 3, 4].
For the full FDA-sourced reference on every storage scenario, see our GLP-1 storage and shelf-life guide.
What if you forget your medication at home
It happens. The options, in rough order of speed:
- Local pharmacy refill. If you're still in the United States, most major chain pharmacies (CVS, Walgreens, Walmart) can pull your prescription on file from another state and dispense locally. Call ahead — Wegovy and Zepbound supply has been tight, so confirm stock before driving over.
- LillyDirect / NovoCare direct shipment. Both manufacturers operate direct-to-patient channels. If you have time (3-5 business days), they can ship Wegovy or Zepbound to a hotel address. Useful for longer trips.
- Telehealth bridge prescription. Most telehealth providers will issue a one-time bridge prescription to a local pharmacy if you contact support and explain the situation.
- Skip the dose. For weekly injectables, missing a single dose is not a clinical emergency. The FDA labels say to take the missed dose within 5 days of the scheduled day; otherwise skip and resume the normal schedule.
International travel
All four injectable GLP-1s and Foundayo are approved in most developed markets, though brand names and pen formats vary. Carrying your US-purchased medication into the EU, UK, Canada, Australia, or most of Asia for personal medical use is generally permitted, but the rules differ by country. A few specific points:
- Bring the original carton and the pharmacy label. Customs officers in most countries will wave through a clearly labeled prescription medication in an original manufacturer carton. Loose pens in a Ziploc invite questions.
- Carry a doctor's letter for longer trips. A simple letter on practice letterhead stating the drug, the dose, and the medical indication covers most customs inquiries. Have it translated into the local language for non-English-speaking destinations if you can.
- Check destination customs rules. Some countries (Japan, Singapore, the UAE) have strict import-by-personal-quantity rules and may require pre-arrival medication import certificates. Check the destination's embassy website at least two weeks before traveling.
Compounded GLP-1 vials and travel
Patients on compounded semaglutide or tirzepatide from a 503A pharmacy face a slightly different travel calculus. The upside: a compounded multi-dose vial is physically smaller than a brand-name pen, which is convenient. The downside: the room-temperature stability window for a compounded vial is not validated by the same large-scale FDA process as the brand pens. The vial's beyond-use date (BUD) is set by the compounding pharmacy under USP <797>, and the room-temperature tolerance varies by formulation.
Practical guidance for compounded vial travel: keep the vial refrigerated when possible, treat the room-temperature window as “a few days at most” unless your pharmacy has documented otherwise, and call the compounding pharmacy before a long trip to ask for the specific stability window for your formulation. They will tell you. If the vial sits at room temperature for longer than the pharmacy's documented window, the conservative call is to discard.
Bottom line
Traveling with a GLP-1 is genuinely easy if you know the numbers. The labeled out-of-fridge windows — 28 days for Wegovy, 56 days for Ozempic, 21 days for Zepbound and Mounjaro, indefinite for Foundayo — cover almost every real travel scenario you'll encounter. The TSA explicitly allows pens, syringes, and frozen ice packs in carry-on. Cargo holds are the enemy. A basic insulated case keeps everything in spec for the duration of any normal trip. And if something goes wrong, the fix is almost always a phone call to your pharmacy or a one-time skipped dose, not a medical emergency.
Related research and tools
- GLP-1 storage and shelf-life: the full FDA reference
- How to inject a GLP-1: step-by-step technique guide
- How to take Foundayo (orforglipron): the daily oral GLP-1 guide
- GLP-1 and surgery: the ASA anesthesia guidance
- GLP-1 drug interaction checker
- GLP-1 washout calculator
- GLP-1 unit converter (mg to units for compounded vials)
Important disclaimer: this article is general patient education and not personalized medical advice. The storage windows quoted come directly from the FDA-approved prescribing information for each drug, but your individual medication, your specific compounded formulation, and your clinical situation may differ. Always defer to the instructions on your pharmacy label, the manufacturer carton, and your prescribing clinician. If you suspect your medication has been damaged by heat, cold, or freezing, do not use it — contact your pharmacy or prescriber for replacement guidance.
References
- 1.Novo Nordisk Inc. WEGOVY (semaglutide) injection — US Prescribing Information, Section 16: How Supplied / Storage and Handling. FDA Approved Labeling. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s024lbl.pdf
- 2.Novo Nordisk Inc. OZEMPIC (semaglutide) injection — US Prescribing Information, Section 16: How Supplied / Storage and Handling. FDA Approved Labeling. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s024lbl.pdf
- 3.Eli Lilly and Company. ZEPBOUND (tirzepatide) injection — US Prescribing Information, Section 16: How Supplied / Storage and Handling. FDA Approved Labeling. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217806s016lbl.pdf
- 4.Eli Lilly and Company. MOUNJARO (tirzepatide) injection — US Prescribing Information, Section 16: How Supplied / Storage and Handling. FDA Approved Labeling. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215866s019lbl.pdf
- 5.Transportation Security Administration (TSA). Traveling with Medication: Carry-On Rules for Liquid Medication, Injectables, and Frozen Ice Packs. TSA.gov. 2025. https://www.tsa.gov/travel/special-procedures/traveling-medication
- 6.Eli Lilly and Company. Lilly receives U.S. FDA approval of Foundayo (orforglipron), the first oral non-peptide GLP-1 receptor agonist for chronic weight management. Eli Lilly Investor Press Release. 2026. https://investor.lilly.com/news-releases